Amsterdam UMC, location VUmc: Multiple Sclerosis trials
The registry lists 13 Multiple Sclerosis studies with Amsterdam UMC, location VUmc as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 3 2Phase 4 2No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple SclerosisNot yet recruitingNCT06627465
- Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the NetherlandsRecruitingNCT06567197
- Multiple Sclerosis Self Monitoring StudyRecruitingNCT06125301Not applicable
- Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple SclerosisRecruitingNCT06068582Not applicable
- Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MSRecruitingNCT05834855Phase 3
- Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and BodyRecruitingNCT05357638Not applicable
- Lifestyle Intervention for Patients With Multiple SclerosisStatus unknownNCT05402501
- Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple SclerosisTerminatedNCT05338450Phase 3
- The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple SclerosisCompletedNCT04478591
- Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).Status unknownNCT04260711Not applicable
- Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple SclerosisStatus unknownNCT04225312Phase 4
- Towards Personalized Dosing of Natalizumab in Multiple SclerosisCompletedNCT03516526Phase 4
- Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive TherapyTerminatedNCT02525367Not applicable